Thank you, Kathy. The goal in my opinion is to get useable and credible and readable information to the FDA review team. Anything Dean does to expedite the process is a plus for the investors. Delay is inevitable with governmental agencys. No way around it. I prefer to focus on the overall aspects of the process and not on critiqueing of the day to day play by play details involved.
Overall Details like:
1. Is Dean a Trustworthy person? From all I see yes, he is.
2. Does the DVis work as advertised? From what I know, yes. Otherwise how could such a hoax be perpetrated for such a long time with Doctors, Radiologists, FDA reviewers and other people experienced in this industry reviewing what is presented by IMGG at RSNA and on the internet and to visitors at the IMGG offices?
3. Is Dean experienced enough with 510k submissions to succeed? Yes, he is. Nearly everyone in the medical field is complaining about the extended delays caused by the FDA involving nearly all the medical device, drug and invasive 510k submissions. So the delay is an FDA problem, not one caused by a lack of experience by Dean.
4. Is Dean more transparent with information than most CEO's in Pennyland or on the OTC.bb? In my experience, YES, he is. I have seen NASDAQ or other Big Board stocks that did not offer any shareholders anywhere near the amount and quality of access such as RSNA, IHUB, Yahoo, F-Book, Money TV, Press Releases< Response to E-mails, an aborted Investors Forum ...closed because of shareholder abuse and misuse...and direct telephone access to both him and Mike, and video tours of IMGG offices with live demos. Providing information without violating the restrictive laws in place for all CEO's is not an easy task.
5. Is there a political or financial conspiracy to hold up the IMGG Dominion so other larger companies can "catch up" to IMGG and get a product approved and to market before IMGG? I find that to be a difficult possibility, but I can not state with any certainty that it could not be happening. However the delays that no one expected involving nearly all the 510k submission over the recent past leads me to think that is not the case.
6. Will the shareholder price per share fluctuate until the FDA decision is made? Of course it will. If approval and success were assured, everyone would be invested in IMGG. Shareholders are taking a risk. If the DVis is approved, we stand to make money. If not, we stand to lose money.
7. Will I continue to hold and invest (and trade) IMGG stock? Yes, I will. As an investor, I will hold some shares for a long term position. As a trader, I will buy some shares on the dips and sell on the increases that make sense to me. We are all here to make money. I know I am. Gather all the information you can, consider all the aspects that are important to you and make decisions based on your knowledge, TA, personal experience and gut feelings.
8. Will IMGG eventually be approved? Yes. Does anyone on this board know when that will be? NO. However, I believe we are in the home stretch and the finish line is near. That is my take on the situation.
PARDON ME SIR, BUT I THINK YOUR GOLD HAS ARRIVED!
